These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 34788328)

  • 21. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.
    Taniguchi M; Rebellato LM; Cai J; Hopfield J; Briley KP; Haisch CE; Catrou PG; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
    Am J Transplant; 2013 Oct; 13(10):2577-89. PubMed ID: 23941128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the Serum Concentration of Angiotensin II Type 1 Receptor Have an Effect on the Severity of COVID-19? A Prospective Preliminary Observational Study among Healthcare Professionals.
    Janc J; Suchański M; Mierzchała-Pasierb M; Woźnica-Niesobska E; Łysenko L; Leśnik P
    J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?
    Philogene MC; Zhou S; Lonze BE; Bagnasco S; Alasfar S; Montgomery RA; Kraus E; Jackson AM; Leffell MS; Zachary AA
    Hum Immunol; 2018 Apr; 79(4):195-202. PubMed ID: 29428484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation.
    Chan AP; Guerra MR; Rossetti M; Hickey MJ; Venick RS; Marcus EA; McDiarmid SV; Farmer DG; Reed EF; Wozniak LJ
    Pediatr Transplant; 2021 May; 25(3):e13987. PubMed ID: 33590644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies.
    Lim MA; Palmer M; Trofe-Clark J; Bloom RD; Jackson A; Philogene MC; Kamoun M
    Hum Immunol; 2017 Apr; 78(4):350-356. PubMed ID: 28284829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
    Giil LM; Kristoffersen EK; Vedeler CA; Aarsland D; Nordrehaug JE; Winblad B; Cedazo-Minguez A; Lund A; Reksten TR
    J Alzheimers Dis; 2015; 47(2):523-9. PubMed ID: 26401573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients.
    Fichtner A; Süsal C; Schröder C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Dragun D; Tönshoff B
    Nephrol Dial Transplant; 2018 Jun; 33(6):1065-1072. PubMed ID: 29444269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
    Richter AG; Shields AM; Karim A; Birch D; Faustini SE; Steadman L; Ward K; Plant T; Reynolds G; Veenith T; Cunningham AF; Drayson MT; Wraith DC
    Clin Exp Immunol; 2021 Aug; 205(2):99-105. PubMed ID: 34082475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient.
    Guzzo I; Morolli F; Camassei FD; Piazza A; Poggi E; Dello Strologo L
    Pediatr Nephrol; 2017 Jan; 32(1):185-188. PubMed ID: 27752765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Angiotensin type 1 receptor antibodies in chronic graft-versus-host disease.
    Chiron A; Bouaziz JD; Carmagnat M; Peffault de Latour R; Lafaurie-Bergeron A; Robin M; Xhaard A; Toubert A; Charron D; Guigue N; Socié G; Bengoufa D
    Transplantation; 2014 Aug; 98(4):470-4. PubMed ID: 24873781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-transplant AT
    Gareau AJ; Wiebe C; Pochinco D; Gibson IW; Ho J; Rush DN; Nickerson PW
    Transpl Immunol; 2018 Feb; 46():29-35. PubMed ID: 29217423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.
    El-Arif G; Khazaal S; Farhat A; Harb J; Annweiler C; Wu Y; Cao Z; Kovacic H; Abi Khattar Z; Fajloun Z; Sabatier JM
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
    Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
    Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
    Liu C; Kang ZY; Yin Z; Xiao Y; Liu W; Zhao Y; Li DH
    Transpl Immunol; 2022 Oct; 74():101674. PubMed ID: 35901953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
    Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
    J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
    Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
    Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients.
    O'Leary JG; Philippe A; Freeman R; Heidecke H; Jennings LW; Catar R; Klintmalm GB; Dragun D
    Transplant Proc; 2021 Apr; 53(3):1019-1024. PubMed ID: 33579550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
    Yu X; Li H; Murphy TA; Nuss Z; Liles J; Liles C; Aston CE; Raj SR; Fedorowski A; Kem DC
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-transplant AT1R antibodies and long-term outcomes in kidney transplant recipients with a functioning graft for more than 5 years.
    Aziz F; Jung-Hynes B; Parajuli S; Redfield RR; Astor BC; Mandelbrot D; Hidalgo L; Djamali A
    Clin Nephrol; 2020 Nov; 94(5):245-251. PubMed ID: 32870149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.